Amneal reports second quarter 2023 financial results

Bridgewater, n.j.--(business wire)--amneal pharmaceuticals, inc. (nyse: amrx) (“amneal” or the “company”) announced its results today for the second quarter ended june 30, 2023. “we are pleased to raise our full year 2023 guidance following another strong quarter. our momentum in the first half of the year underscores the solid execution of our strategy and ability to drive continued growth across our diversified portfolio. we expect many key catalysts ahead, including complex generics launches.
AMRX Ratings Summary
AMRX Quant Ranking